
    George PIECZENIK, Plaintiff-Appellant, v. BAYER CORPORATION, Bayer Cropscience (New Jersey) Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Healthcare, LLC, Bayer Materialscience LLC, Bayer Pharma Chemicals Inc., and Schering Berlin Inc., Defendants-Appellees, and Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Aventis Inc., Aventis Pharmaceuticals Inc., Boehringer Ingelheim Vetmedica, Inc., Boehringer Ingelheimroxane, Inc., Medimmune LLC, Novartis Corporation, Novartis, Pharmaceutical Corporation, Novartis Vaccines and Diagnostics, Inc., Sanofi Aventis U.S. Inc., Sanofi-Aventis U.S. LLC, Siemens Corporation, Siemens Diagnostics Finance Co. LLC, Siemens Healthcare Diagnostics Inc., and Siemens Medical Solutions USA, Inc., Defendants-Appellees, and Abbott Laboratories, Abbott Laboratories, Inc., and Solvay Pharmaceuticals, Inc., Defendants-Appellees, and Allergan USA, Inc., Corning Incorporated, Gilead Sciences, Inc., Howard Hughes Medical Institute, and Qiagen Incorporated, Defendants-Appellees, and Amgen USA, Inc. and Amgen, Inc., Defendants-Appellees, and Antyra, Inc., Defendant-Appellee, and Baxter Diagnostics Inc., Monsanto AG Products LLC, Monsanto Company, Onyx Pharmaceuticals, Inc., Zymogenetics, Inc., and Zymogenetics, LLC, Defendants-Appellees, and Biogen Idec Inc., Biogen Idec U.S. Corporation, and Medarex, Inc. Defendants-Appellees, and Bracco Diagnostics Inc., Defendant-Appellee, and Centocor Ortho Biotech Products, L.P., Centocor Ortho Biotech Services, Centocor Ortho Biotech, Inc., Johnson & Johnson, Ortho-McNeil Janssen Scientific Affairs, LLC, Ortho-McNeil Pharmaceutical, Inc., and Ortho-McNeil, Inc., Defendants-Appellees, and Dyax Corporation, Forest Laboratories, Inc., Genzyme Corporation, GlaxoSmithKline LLC, and Perkinelmer Health Sciences, Inc., Defendants-Appellees, and E.I. Dupont De Nemours & Company, Defendant-Appellee, and GE Healthcare Biosciences Bioprocess Corp., GE Healthcare Inc., GE Healthcare Strategic Sourcing Corporation, and GE Healthcare Biosciences Corp., Defendants-Appellees, and International Business Machines Corp., Defendant-Appellee, and Invitrogen Corporation, Defendant-Appellee, and Novo Nordisk Inc., Defendant-Appellee, and Solvay Chemicals, Inc., Defendant-Appellee, and The Dow Agrosciences LLC, The Dow Chemical Company (Delaware), and The Dow Corning Corporation, Defendant-Appellees, and Bayer Pharmaceuticals Corporation, Diversa Chemicial Technologies (NJ), Inc., and John Does 1 Through 61, Defendants.
    No. 2011-1385.
    United States Court of Appeals, Federal Circuit.
    July 11, 2011.
    
      Chad J. Peterman, Patterson, Belknap Webb & Tyler LLP, Jennifer L. Larson, Arnold & Porter, LLP, Laura E. Kraw-czyk, Troutman Sanders LLP, Melissa B. Francis, Mayer Brown, LLP, Anne B. Sek-el, Foley & Lardner LLP, Elizabeth S. Hyon, Orrick, Herrington & Sutcliffe LLP, New York, NY, Liza M. Walsh, Richard D. Catenacci, Connell Foley LLP, David W. Field, Matthew R. Savare, Lowenstein Sandler, P.C., Robert M. Goodman, Green-baum, Rowe, Smith & Davis, David Leit, Lowenstein Sandler, P.C., Roseland, NJ, Michael R. Griffinger, Gibbons P.C., Cynthia S. Betz, McCarter & English, LLP, Donald A. Robinson, Robinson & Livelli, Arnold B. Calmann, Saiber LLC, Alice H. Lee, Gibbons P.C., Newark, NJ, Jane E. Keene, Plevy & Keene LLP, Trenton, NJ, Alexander J. Anglim, Greenberg Traurig LLP, Florham Park, NJ, Robert J. Schoenberg, Riker, Danzig, Scherer, Hy-land, Morristown, NJ, for Defendants-Ap-pellees.
    George Pieczenik, Stockton, NJ, pro se.
   ON MOTION

ORDER

Upon consideration of George Pieczen-ik’s unopposed motion to dismiss Syngenta Crop Protection, Inc. et al. from this appeal,

It Is Ordered That:

The motion is granted. The revised official caption is reflected above.  